Platelet activation and degradation in an experimental extracorporeal system. A comparison between a silicone membrane and a hollow-fibre oxygenator

Perfusion

Volumn 11, Issue 5, 1996, Pages 383-388

  Mellgren, K ^a   Skogby, M ^a   Jarnas A ^a   Friberg, L G ^a   Wadenvik, H ^a   Mellgren, G ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; BIOMATERIAL; ELECTROLYTE; FIBRINOGEN RECEPTOR; GLUCOSE; GLYCOCALICIN; HEMOGLOBIN; MARKER; SEROTONIN; SILICONE;

ARTICLE; BIOCOMPATIBILITY; BLOOD; BLOOD GAS ANALYSIS; BLOOD LEVEL; CONTROLLED STUDY; DEGRADATION; ELECTROLYTE BLOOD LEVEL; EXTRACORPOREAL OXYGENATION; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; OXYGENATOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE MEMBRANE;

EID: 0029772324     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919601100505     Document Type: Article

References (12)

1. Zwischenberger JB, Nguyen TT, Upp JR et al. Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization. J Thorac Cardiovasc Surg 1994; 107: 838-49.
2. Cilley RE, Zwischenberger JB, Andrews AF, Bowerman RA, Roloff DW, Bartlett RH. Intracranial haemorrhage during extracorporeal membrane oxygenation in neonates. Pediatrics 1986; 78: 699-704.
3. Plötz FB, van Oeveren W, Bartlett RH, Wildevuur CRH. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg 1993; 105: 823-32.
4. Harker LA, Malpass TW, Branson HE, Hessel II EA, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. Blood 1980; 56: 824-33.
5. Mellgren K, Friberg LG, Hedner T, Mellgren G, Wadenvik H. Blood platelet activation and membrane glycoprotein changes during extracorporeal life support (ECLS). In vitro studies. Int J Artif Organs 1995; 18: 315-21.
6. Rinder CS, Gaal D, Student LA, Smith BR. Platelet-leucocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 107: 280-88.
7. Videm V, Mollnes TE, Garred P, Svennevig JL. Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg 1991; 101: 654-60.
8. Kissinger PT, Bruntlett CS, Davis GC, Felice LJ, Riggin RM, Shoup RE. Recent developments in the clinical assessment of the metabolism of aromatics by high-performance, reversed-phase chromatography with amperometric detection. Clin Chem 1977; 23: 1449-55.
9. Swolin B, Roberts D, Waldenström J. Quantitative determination of plasma hemoglobin using dicarboxidine. Clin Chem Acta 1982; 121: 389-91.
10. Mellgren K, Friberg LG, Mellgren G, Hedner T, Wennmalm Å, Wadenvik H. Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg 1996; 61: 1194-98.
11. Menghini A. Oxygenator design: a global approach. Perfusion 1993; 8: 87-92.
12. Courtney JM, Forbes CD. Thrombosis on foreign surfaces. Br Med Bull 1994; 50: 966-81.